Efficacy of Rituximab in children with Acute Lymphoblastic Leukemia
Phase 3
- Conditions
- Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]Health Condition 2: null- Acute Lymphoblastic Leukemias
- Registration Number
- CTRI/2017/12/010897
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Diagnosis of B Cell Acute Lymphoblastic Leukemia
2.CD 20 expression in >20 % of blast cells
3.Willing to consent for the study
Exclusion Criteria
1.Recieved previous treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method